Malarvili M B, Alexie Mushikiwabeza, Dahari Nadhira, Kamarudin Anhar
School of Biomedical and Health Science Engineering, Universiti Teknologi Malaysia, Skudai, Johor Bahru 81310, Malaysia.
College of Science and Technology (CST), Center or Excellence in Biomedical Engineering and E-Health (CEBE), University of Rwanda, KN 67 Street Nyarugenge, Kigali 3900, Rwanda.
Life (Basel). 2021 Oct 17;11(10):1101. doi: 10.3390/life11101101.
In November 2019, the novel coronavirus disease COVID-19 was reported in Wuhan city, China, and was reported in other countries around the globe. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Strategies such as contact tracing and a vaccination program have been imposed to keep COVID-19 under control. Furthermore, a fast, noninvasive and reliable testing device is needed urgently to detect COVID-19, so that contact can be isolated and ringfenced before the virus spreads. Although the reverse transcription polymerase chain reaction (RT-PCR) test is considered the gold standard method for the diagnosis of SARS-CoV-2 infection, this test presents some limitations which cause delays in detecting the disease. The antigen rapid test (ART) test, on the other hand, is faster and cheaper than PCR, but is less sensitive, and may limit SARS-CoV-2 detection. While other tests are being developed, accurate, noninvasive and easy-to-use testing tools are in high demand for the rapid and extensive diagnosis of the disease. Therefore, this paper reviews current diagnostic methods for COVID-19. Following this, we propose the use of expired carbon dioxide (CO) as an early screening tool for SARS-CoV-2 infection. This system has already been developed and has been tested on asthmatic patients. It has been proven that expired CO, also known as capnogram, can help differentiate between respiratory conditions and, therefore, could be used to detect SARS-CoV-2 infection, as it causes respiratory tract-related diseases.
2019年11月,中国武汉市报告了新型冠状病毒病COVID-19,随后全球其他国家也有相关报告。COVID-19由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引起。为控制COVID-19,已实施接触者追踪和疫苗接种计划等策略。此外,迫切需要一种快速、无创且可靠的检测设备来检测COVID-19,以便在病毒传播之前隔离并圈定接触者。尽管逆转录聚合酶链反应(RT-PCR)检测被认为是诊断SARS-CoV-2感染的金标准方法,但该检测存在一些局限性,导致疾病检测出现延迟。另一方面,抗原快速检测(ART)比PCR检测更快、更便宜,但敏感性较低,可能会限制SARS-CoV-2的检测。虽然其他检测方法正在研发中,但对于该疾病的快速广泛诊断,准确、无创且易于使用的检测工具需求很大。因此,本文综述了当前COVID-19的诊断方法。在此之后,我们提出将呼出二氧化碳(CO)用作SARS-CoV-2感染的早期筛查工具。该系统已经研发出来,并已在哮喘患者身上进行了测试。事实证明,呼出的CO,也称为二氧化碳图,有助于区分不同的呼吸道疾病,因此可用于检测SARS-CoV-2感染,因为它会引发呼吸道相关疾病。